Previous close | 3.5000 |
Open | 3.5000 |
Bid | 0.2000 |
Ask | 0.7000 |
Strike | 50.00 |
Expiry date | 2024-07-19 |
Day's range | 3.5000 - 3.5000 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
Intra-Cellular (ITCI) reports first-quarter 2024 results, wherein both earnings and revenues beat estimates, driven by strong Caplyta sales.
Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.